Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 070311
Company: HIKMA
Company: HIKMA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| DIAZEPAM | DIAZEPAM | 50MG/10ML (5MG/ML) | INJECTABLE;INJECTION | Prescription | AP | No | No |
| DIAZEPAM | DIAZEPAM | 5MG/ML (5MG/ML) | INJECTABLE;INJECTION | Discontinued | None | No | No |
| DIAZEPAM | DIAZEPAM | 10MG/2ML (5MG/ML) | INJECTABLE;INJECTION | Discontinued | None | No | No |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 11/12/2021 | SUPPL-22 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/070311s022lbl.pdf |